1,169
Participants
Start Date
February 28, 2014
Primary Completion Date
December 27, 2022
Study Completion Date
June 8, 2023
Placebo
Administered IV
Solanezumab
Administered IV
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Parkville
New York University Medical Center, New York
Weill Cornell Medical College, New York
Mount Sinai School of Medicine, New York
Columbia University Medical Center, New York
Dent Neurological Institute, Amherst
University of Rochester, Rochester
University of Pittsburgh Medical Center, Pittsburgh
Drexel University College of Medicine at EPPI, Philadelphia
University of Pennsylvania Hospital, Philadelphia
Georgetown University Hospital, Washington D.C.
Howard University Hospital, Washington D.C.
Johns Hopkins University School of Medicine, Baltimore
Wake Forest University School of Medicine, Winston-Salem
Roper Hospital, Charleston
Emory University, Atlanta
Compass Research -The Villages, The Villages
Mayo Clinic-Jacksonville, Jacksonville
Compass Research - Orlando, Orlando
Wien Center for Clinical Research, Miami Beach
Premiere Research Institute at Palm Beach Neurology, West Palm Beach
Brain Matters Research, Delray Beach
University of South Florida, Tampa
University of Alabama at Birmingham, Birmingham
University of Kentucky, Lexington
Case Western Reserve University, Beachwood
Indiana University School of Medicine, Indianapolis
University of Michigan, Ann Arbor
University of Iowa, Iowa City
University of Wisconsin-Madison Hospital and Health Clinic, Madison
Mayo Clinic, Rochester
Northwestern University, Chicago
Rush Alzheimer's Disease Center, Chicago
Great Lakes Clinical Trials, Chicago
Washington University School of Medicine, St Louis
University of Kansas Hospital, Fairway
Univ of Nebraska Med Center, Omaha
Tulsa Clinical Research LLC, Tulsa
University of Texas Southwestern Medical Center at Dallas, Dallas
Baylor College of Medicine, Houston
Houston Methodist, Houston
Banner Health Research Institute, Phoenix
Barrow Neurological Institute, Phoenix
Banner Sun Health Research Institute, Sun City
Cleveland Clinic of Las Vegas, Las Vegas
University of Southern California School of Medicine, Los Angeles
University of California - Los Angeles, Los Angeles
University of California - San Diego, La Jolla
Institute for Memory Impairment & Neurological Disorders, Irvine
Syrentis Clinical Research, Santa Ana
Univ of California Irvine College of Medicine, Orange
Univ of California San Francisco, San Francisco
Veterans Affairs Medical Center Palo Alto, Palo Alto
University of California, Davis - Health Systems, Walnut Creek
Sutter Medical Group, Sacramento
Oregon Health and Science University, Portland
University of Washington School of Medicine, Seattle
Yale University School of Medicine, New Haven
Pennington Biomedical Research Center, Baton Rouge
Brigham and Womens Hospital, Boston
Boston University Medical Center, Boston
Butler Hospital, Providence
Rhode Island Hospital, Providence
For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., London
For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., Toronto
Sunnybrook Health Sciences Centre, Toronto
For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., Vancouver
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bunkyō City
Collaborators (1)
Alzheimer's Therapeutic Research Institute
OTHER
Eli Lilly and Company
INDUSTRY